Reprogrammed cells help mice with Parkinson’s
Tumour fears allayed
Researchers at MIT have found that "reprogrammed" stem cells can repair the neurons of mice with a model of Parkinson’s disease. In a study published in the Proceedings of the National Academy of Sciences, Rudolph Jaenisch, a prominent stem cell scientist, found that the technique developed by Japanese researcher Shinya Yamanaka can be used to turn skin cells into functioning neurons. The cells transplant well and repair brain defects. Despite their cancer-causing potential, the researchers found that when the reprogrammed cells were purified carefully, none of the rats developed tumours.
Until now, scientists have been investigating stem cells derived from therapeutic cloning or from aborted foetus as a cure for Parkinson’s disease. However, the journal Technology Review says that the reprogrammed cells (or induced pluripotent stem cells) "offer a way to avoid the use of embryos as well as the technical challenges of nuclear transfer. And if the cells came from a patient’s own skin, there would be no potential complications from immune rejection of foreign tissue.". ~ Technology Review, Apr 8
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...